Scoping review: biomarkers in chronic inducible urticaria. (PubMed, Front Immunol) - Oct 10, 2026 - "This scoping review aimed to map current evidence on diagnostic, prognostic, predictive, and monitoring or treatment-response biomarkers in CIndU, with a focus on H1-antihistamine and omalizumab therapy...Integrative multi-omics approaches, such as those being applied in the SKINERGY CIndU pilot study within the Next Generation ImmunoDermatology consortium, hold promise for advancing biomarker discovery. External validation in large, well-characterized cohorts through international networks, such as Urticaria Centers of Reference and Excellence (UCARE), will be pivotal for clinical translation."
Biomarker • Journal • Review • Allergy • Chronic Spontaneous Urticaria • Dermatology • Immunology • Urticaria
|
|
Fauve R van den Berge; Heike Röckmann; Juliette V L Simons; Martijn B A van Doorn
|